Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
IRVINGTON, NY--(Marketwire - April 30, 2009) - Electro-Optical Sciences (NASDAQ: MELA) today announced that the company will ring the NASDAQ Stock Market Opening Bell on Monday, May 4, 2009 at 9:30...
-
MALVERN, PA--(Marketwire - April 30, 2009) - Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that executive management will participate in the Bank of America and Merrill Lynch 2009...
-
MALVERN, PA--(Marketwire - April 28, 2009) - Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has...
-
YOQNEAM, ISRAEL--(Marketwire - April 16, 2009) - Given Imaging (NASDAQ: GIVN), the global leader in capsule endoscopy, today announced that the company will host conference calls on Thursday, May 7,...
-
MALVERN, PA--(Marketwire - April 15, 2009) - Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the first quarter 2009 on Wednesday, May 6,...
-
INCLINE VILLAGE, NV--(Marketwire - March 26, 2009) - PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced revenue guidance for the first quarter ended March 31, 2009 of approximately $60 million,...
-
MALVERN, PA--(Marketwire - March 20, 2009) - Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that William T. McKee has joined its Board of...
-
INCLINE VILLAGE, NV--(Marketwire - March 19, 2009) - PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced an adjustment to the conversion rate for its 2.75% Convertible Subordinated Notes due...
-
MALVERN, PA--(Marketwire - March 18, 2009) - Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that executive management will participate in Citi's 4th Annual Biotech Day to be held April...
-
INCLINE VILLAGE, NV--(Marketwire - March 17, 2009) - PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced an adjustment to the conversion rate for its 2.00% Convertible Senior Notes due February...